Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Beauty Health (SKIN) Acquisitions (2021 - 2022)

SkinHealth Systems has reported Acquisitions over the past 2 years, most recently at -$4.9 million for Q3 2022.

Quarterly Acquisitions fell 127.37% to -$4.9 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $13.1 million through Dec 2022, up 565.62% year-over-year, with the annual reading at $22.9 million for FY2021, N/A changed from the prior year.
Acquisitions was -$4.9 million for Q3 2022 at SkinHealth Systems, down from $18.0 million in the prior quarter.
Over five years, Acquisitions peaked at $18.0 million in Q3 2021 and troughed at -$20.8 million in Q2 2021.